These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29305538)

  • 1. False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes.
    Theron G; Venter R; Smith L; Esmail A; Randall P; Sood V; Oelfese S; Calligaro G; Warren R; Dheda K
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29305538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?
    Theron G; Venter R; Calligaro G; Smith L; Limberis J; Meldau R; Chanda D; Esmail A; Peter J; Dheda K
    Clin Infect Dis; 2016 Apr; 62(8):995-1001. PubMed ID: 26908793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
    Bunyasi EW; Tameris M; Geldenhuys H; Schmidt BM; Luabeya AK; Mulenga H; Scriba TJ; Hanekom WA; Mahomed H; McShane H; Hatherill M
    PLoS One; 2015; 10(11):e0141623. PubMed ID: 26554383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
    Khalil KF; Butt T
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
    Kendall EA; Kamoga C; Kitonsa PJ; Nalutaaya A; Salvatore PP; Robsky K; Nakasolya O; Mukiibi J; Isooba D; Cattamanchi A; Kato-Maeda M; Katamba A; Dowdy DW
    PLoS One; 2019; 14(7):e0220251. PubMed ID: 31339935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
    Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
    J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
    Lee HN; Kim JI; Kim YH
    PLoS One; 2021; 16(5):e0250616. PubMed ID: 33939723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performance of an in-house loop-mediated isothermal amplification for the rapid detection of Mycobacterium tuberculosis in sputum samples in comparison with Xpert MTB/RIF, microscopy and culture.
    Phetsuksiri B; Klayut W; Rudeeaneksin J; Srisungngam S; Bunchoo S; Toonkomdang S; Wongchai T; Nakajima C; Suzuki Y
    Rev Inst Med Trop Sao Paulo; 2020; 62():e36. PubMed ID: 32520211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results.
    Boyles TH; Hughes J; Cox V; Burton R; Meintjes G; Mendelson M
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):876-8. PubMed ID: 24902569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
    Luetkemeyer AF; Firnhaber C; Kendall MA; Wu X; Mazurek GH; Benator DA; Arduino R; Fernandez M; Guy E; Johnson P; Metchock B; Sattler F; Telzak E; Wang YF; Weiner M; Swindells S; Sanne IM; Havlir DV; Grinsztejn B; Alland D;
    Clin Infect Dis; 2016 May; 62(9):1081-8. PubMed ID: 26839383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the G4 Xpert
    Dharan NJ; Blakemore R; Sloutsky A; Kaur D; Alexander RC; Ghajar M; Musser KA; Escuyer VE; Rowlinson MC; Crowe S; Laniado-Laborin R; Valli E; Nabeta P; Johnson P; Alland D
    BMC Infect Dis; 2016 Dec; 16(1):764. PubMed ID: 27993132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.
    Davis JL; Kawamura LM; Chaisson LH; Grinsdale J; Benhammou J; Ho C; Babst A; Banouvong H; Metcalfe JZ; Pandori M; Hopewell PC; Cattamanchi A
    Am J Respir Crit Care Med; 2014 Jun; 189(12):1551-9. PubMed ID: 24869625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GeneXpert MTB/RIF Outperforms Mycobacterial Culture in Detecting
    Shi J; Dong W; Ma Y; Liang Q; Shang Y; Wang F; Huang H; Pang Y
    Biomed Res Int; 2018; 2018():1514381. PubMed ID: 29805972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTi
    Berhanu RH; David A; da Silva P; Shearer K; Sanne I; Stevens W; Scott L
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.